文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

膜联蛋白A1激活G蛋白偶联甲酰肽受体2依赖的内皮型一氧化氮合酶通路减轻脓毒症相关急性肺损伤

[Annexin A1 activates the G protein-coupled formyl peptide receptor type 2-dependent endothelial nitric oxide synthase pathway to alleviate sepsis associated acute lung injury].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论大鼠实验显示膜联蛋白A1模拟肽Ac2-26经FPR2依赖的eNOS通路改善脓毒症相关急性肺损伤,FPR2抑制剂WRW4可阻断该效应。

研究将24只雄性SD大鼠随机分为正常对照组、脂多糖诱导肺损伤模型组(LPS组)、LPS+膜联蛋白A1模拟肽组(LPS+Ac2-26组)和LPS+Ac2-26+FPR2抑制剂组(LPS+Ac2-26+WRW4组),每组6只。造模前第3天经尾静脉注射Ac2-26 1 mg/kg(LPS+Ac2-26组)或Ac2-26 1 mg/kg+WRW4 2.2 mg/kg(LPS+Ac2-26+WRW4组),对照组和LPS组注射等体积生理盐水。造模48小时后检测氧合指数、肺湿/干重比、病理评分及炎症因子、氧化应激指标和eNOS/iNOS/NF-κB蛋白表达。结果显示Ac2-26可提高氧合指数和IL-10水平、降低湿/干重比、病理评分及TNF-α、IL-1β、IL-6、MDA、MPO水平,并上调eNOS、下调iNOS和NF-κB表达;WRW4可逆转上述改善。结论为膜联蛋白A1通过激活FPR2依赖的eNOS通路改善脓毒症相关肺损伤。

要点

  • LPS+Ac2-26组较LPS组氧合指数和肺组织IL-10显著升高,湿/干重比、病理评分及TNF-α、IL-1β、IL-6、MDA、MPO显著降低。
  • LPS+Ac2-26+WRW4组较LPS+Ac2-26组氧合指数降低(132.16±24.00 vs. 248.67±18.70 mmHg)、IL-10降低(27.30±3.04 vs. 36.10±3.92 ng/L),均P<0.05。
  • WRW4组较Ac2-26组湿/干重比(5.29±0.02 vs. 4.83±0.02)、病理评分(5.00±0.28 vs. 2.67±0.52)及TNF-α、IL-1β、IL-6、MDA、MPO均显著升高(均P<0.05)。
  • Ac2-26组较LPS组eNOS/β-actin上调(0.25±0.01 vs. 0.14±0.01)、iNOS/β-actin(0.09±0.02 vs. 0.12±0.02)和NF-κB/β-actin(0.35±0.06 vs. 0.59±0.13)下调,均P<0.05。
  • WRW4组较Ac2-26组eNOS/β-actin下调(0.17±0.02 vs. 0.25±0.01)、iNOS/β-actin(0.12±0.02 vs. 0.09±0.02)和NF-κB/β-actin(0.52±0.10 vs. 0.35±0.06)上调,均P<0.05。

适用人群与场景

  • 雄性SD大鼠24只,随机分为4组,每组6只:正常对照组、LPS诱导肺损伤模型组、LPS+Ac2-26组、LPS+Ac2-26+WRW4组。

处置流程与药物剂量

  • 造模前第3天,LPS+Ac2-26组经尾静脉注射Ac2-26 1 mg/kg;LPS+Ac2-26+WRW4组经尾静脉注射Ac2-26 1 mg/kg和WRW4 2.2 mg/kg;对照组和LPS组注射等体积生理盐水。
  • 造模48小时后麻醉大鼠,取颈动脉血检测氧合指数(OI),处死后取肺组织测定湿/干重比、光镜下病理评分,ELISA检测TNF-α、IL-1β、IL-6、IL-10、MDA、MPO,Western blotting检测eNOS、iNOS、NF-κB蛋白表达。

研究设计与关键结果

  • 光镜下,LPS+Ac2-26组较LPS组肺组织炎症细胞浸润减轻、肺泡间隔厚度改善;LPS+Ac2-26+WRW4组较LPS+Ac2-26组炎症细胞浸润加重、肺泡间隔增厚,提示WRW4逆转ANXA1的肺改善作用。
  • 与对照组比较,LPS组氧合指数显著降低,肺湿/干重比、病理评分及TNF-α、IL-1β、IL-6、MDA、MPO水平显著升高。
  • 与LPS组比较,LPS+Ac2-26组氧合指数和肺组织IL-10水平显著升高,湿/干重比、病理评分及TNF-α、IL-1β、IL-6、MDA、MPO水平显著降低。
  • 与LPS+Ac2-26组比较,LPS+Ac2-26+WRW4组氧合指数降低[132.16±24.00 vs. 248.67±18.70 mmHg(1 mmHg≈0.133 kPa)]、IL-10降低(27.30±3.04 vs. 36.10±3.92 ng/L),均P<0.05;湿/干重比(5.29±0.02 vs. 4.83±0.02)、病理评分(5.00±0.28 vs. 2.67±0.52)、TNF-α(39.80±4.36 vs. 32.10±2.15 ng/L)、IL-1β(200.00±15.68 vs. 152.60±9.74 ng/L)、IL-6(181.50±18.02 vs. 148.50±7.34 ng/L)、MDA(82.01±8.22 vs. 70.43±5.69 mmol/mg)、MPO(6.50±0.32 vs. 4.60±0.56 pg/mg)均显著升高,均
  • Western blotting显示,与对照组比较,LPS组eNOS、iNOS、NF-κB表达显著上调;与LPS组比较,LPS+Ac2-26组eNOS/β-actin显著上调(0.25±0.01 vs. 0.14±0.01,P<0.05),iNOS/β-actin(0.09±0.02 vs. 0.12±0.02)和NF-κB/β-actin(0.35±0.06 vs. 0.59±0.13)显著下调,均P<0.05;与LPS+Ac2-26组比较,LPS+Ac2-26+WRW4组eNOS/β-actin显著下调(0.17±0.02 vs. 0.25±0.01,P<0.05),iNOS/β-actin(0.12±0.02 vs. 0.09±0.02)和NF-κB/β-actin(0.52±0.10 vs. 0.35±0.06)显著上调,均P<0.05。

证据类型、等级与局限

  • 证据类型:动物实验(雄性SD大鼠,每组6只)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文结论:膜联蛋白A1可通过激活FPR2依赖的eNOS通路改善脓毒症相关肺损伤,提示该通路可能为脓毒症相关急性肺损伤的干预靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate whether annexin A1 (ANXA1) improves sepsis-induced lung injury by activating G protein-coupled formyl peptide receptor type 2 (FPR2)-dependent endothelial nitric oxide synthase (eNOS) pathway.

METHODS: Twenty-four male SD rats were randomly divided into normal group (Control group), lipopolysaccharide (LPS) induced lung injury model group (LPS group), LPS+ANXA1 mimetic peptide group (LPS+Ac2-26 group) and LPS+ANXA1 mimetic peptide+FPR2 inhibitor group (LPS+Ac2-26+WRW4 group), with 6 rats in each group. On the third day before modeling, rats of the LPS+Ac2-26 group were injected with 1 mg/kg Ac2-26 by the tail vein and rats of LPS+Ac2-26+WRW4 group were injected with 1 mg/kg Ac2-26 and 2.2 mg/kg WRW4 by the tail vein. The rats of control group and LPS group were injected same volume of physiological saline. After 48 hours of modeling, the rats were anesthetized and the carotid blood was taken to detect the oxygenation index (OI). Lung tissue was taken from the euthanized rats. The wet/dry (W/D) ratio was determined. The pathological changes of lung tissue were observed under light microscope and pathological score was performed. The levels of tumor necrosis factor-α (TNF-α), interleukins (IL-1β, IL-6, IL-10), malondialdehyde (MDA) and myeloperoxidase (MPO) were detected by enzyme-linked immunosorbent assay (ELISA). The protein expressions of eNOS, inducible nitric oxide synthase (iNOS) and nuclear factor-κB (NF-κB) were detected by Western blotting.

RESULTS: Under light microscope, compared with LPS group, the infiltration degree of inflammatory cells in the lung tissue of LPS+Ac2-26 group was reduced, and the thickness of the alveolar septum was improved. The degree of inflammatory cell infiltration in the lung tissue of LPS+Ac2-26+WRW4 group was more severe than that of LPS+Ac2-26 group, and the thickness of the alveolar septum increased. These findings suggested that ANXA1 significantly inhibited inflammatory cell infiltration and improved alveolar septal thickness, WRW4 reversed the lung improvement effects of ANXA1. Compared with control group, OI in LPS group was significantly decreased, and W/D ratio, pathological score and TNF-α, IL-1β, IL-6, MDA and MPO levels in lung tissue were significantly increased. Compared with LPS group, OI and IL-10 levels in lung tissue were significantly increased in LPS+Ac2-26 group, while W/D ratio, pathological score, TNF-α, IL-1β, IL-6, MDA and MPO levels in lung tissue were significantly decreased. These results indicated that ANXA1 can improve the oxygenation capacity, improve lung tissue leakage, reduce edema, and inhibit lung tissue inflammation in rats with lung injury. Compared with LPS+Ac2-26 group, the LPS+Ac2-26+WRW4 group showed significant decreases in OI and lung tissue IL-10 level [OI (mmHg, 1 mmHg ≈ 0.133 kPa): 132.16±24.00 vs. 248.67±18.70, IL-10 (ng/L): 27.30±3.04 vs. 36.10±3.92, both P < 0.05], the lung tissue W/D ratio, pathological score and levels of TNF-α, IL-1β, IL-6, MDA and MPO were significantly increased [W/D ratio: 5.29±0.02 vs. 4.83±0.02, pathological score: 5.00±0.28 vs. 2.67±0.52, TNF-α (ng/L): 39.80±4.36 vs. 32.10±2.15, IL-1β (ng/L): 200.00±15.68 vs. 152.60±9.74, IL-6 (ng/L): 181.50±18.02 vs. 148.50±7.34, MDA (mmol/mg): 82.01±8.22 vs. 70.43±5.69, MPO (pg/mg): 6.50±0.32 vs. 4.60±0.56, all P < 0.05]. These results suggested that WRW4 could block the above improvement of ANXA1. Western blotting results showed that compared with control group, the expression of eNOS, iNOS and NF-κB in LPS group was significantly up-regulated. Compared with LPS group, the protein expression of eNOS in LPS+Ac2-26 group was significantly up-regulated (eNOS/β-actin: 0.25±0.01 vs. 0.14±0.01, P < 0.05), and the protein expression of iNOS and NF-κB was significantly down-regulated (iNOS/β-actin: 0.09±0.02 vs. 0.12±0.02, NF-κB/β-actin: 0.35±0.06 vs. 0.59±0.13, both P < 0.05). These findings suggested that ANXA1 might activate the eNOS pathway and down-regulate the expression of NF-κB. Compared with LPS+Ac2-26 group, the protein expression of eNOS in LPS+Ac2-26+WRW4 group was significantly down-regulated (eNOS/β-actin: 0.17±0.02 vs. 0.25±0.01, P < 0.05), while the protein expression of iNOS and NF-κB was significantly up-regulated (iNOS/β-actin: 0.12±0.02 vs. 0.09±0.02, NF-κB/β-actin: 0.52±0.10 vs. 0.35±0.06, both P < 0.05). These results suggested that WRW4 blocked the activation of the eNOS pathway by ANXA1.

CONCLUSIONS: ANXA1 can improve lung injury associated with sepsis by activating FPR2-dependent eNOS pathway.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen Y, He Y, Qin H, et al. [Annexin A1 activates the G protein-coupled formyl peptide receptor type 2-dependent endothelial nitric oxide synthase pathway to alleviate sepsis associated acute lung injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39380512. doi:10.3760/cma.j.cn121430-20240226-00160

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。